MYD88 and breast carcinoma: In the present study, we have shown the proliferation of two different types of breast cancer cell lines, viz, a triple-negative breast cancer cell MDA-MB-231 and estrogen receptor-positive cells—T47D cells by induction of the TLR3 ligand, which was downregulated by the addition of the MyD88 inhibitor.